Source: Virtual Congress 2020 – Pulmonary embolism and beyond
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
H. Onishi (Kobe City, Japan), Y. Taniguchi (Kobe City, Japan), Y. Matsuoka (Kobe City, Japan), Y. Izawa (Kobe City, Japan), Y. Tsuboi (Kobe City, Japan), H. Otake (Kobe City, Japan), S. Satomi-Kobayashi (Kobe City, Japan), N. Emoto (Kobe City, Japan), K. Hirata (Kobe City, Japan). Interventional Treatment in Chronic Thromboembolic Pulmonary Hypertension with Microvasculopathy. 3452

Member's Comments

No comment yet.

Related content which might interest you: Treatment of Chronic Thromboembolic Pulmonary Hypertension: A new approach Source: International Congress 2018 – CC2 Broad spectrum of chronic thromboembolic pulmonary hypertension Year: 2018 Clinical efficacy of Macitentan in patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension Source: International Congress 2018 – Pulmonary hypertension: therapy Year: 2018 Chronic Thromboembolic Pulmonary Hypertension related to ICD Source: International Congress 2018 – CC2 Broad spectrum of chronic thromboembolic pulmonary hypertension Year: 2018 Poor Subpleural Perfusion as a predictor of Failure after Balloon Pulmonary Angioplasty for non-operable Chronic Thromboembolic Pulmonary Hypertension Source: International Congress 2017 – Outcomes and new treatment strategies in pulmonary hypertension Year: 2017 Iron Deficiency in Chronic Thromboembolic Pulmonary Hypertension Source: International Congress 2019 – Haemodynamics and chronic thromboembolic pulmonary hypertension Year: 2019 Late Breaking Abstract - Balloon Pulmonary Angioplasty for the Treatment of Non Operable Chronic Thromboembolic Pulmonary Hypertension – Initial experience of a Belgian Center Source: International Congress 2018 – Chronic thromboembolic pulmonary hypertension Year: 2018 Frequency and risk factors for Chronic Thromboembolic Pulmonary Hypertension after a first unprovoked Pulmonary Embolism: results from PADIS-studies. Source: Virtual Congress 2021 – Non-pulmonary arterial hypertension pulmonary hypertension Year: 2021 Diagnosis and Treatment of Chronic Pulmonary Embolism Source: School Course 2014 - Pulmonary Hypertension and Pulmonary Vascular Disease Year: 2014 Diagnosis and Treatment of Chronic Pulmonary Embolism Source: ERS Skills course - Pulmonary hypertension and pulmonary vascular disease Year: 2018 Effects on Right Ventricular size and function by Riociguat in Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension (The RIVER Study) Source: International Congress 2018 – Pulmonary hypertension: therapy Year: 2018 Pulmonary Hypertension Source: Research Seminar 2013 - Optimising models for human lung diseases and drug development Year: 2013 Pulmonary Hypertension Source: Eur Respir Rev 2009; 18: 193-194 Year: 2009 Incidence of Chronic Thromboembolic Pulmonary Hypertension (CTEPH) at six months of a Pulmonary Embolism (PE). OSIRIS Study Source: International Congress 2017 – Prognostic factors and outcomes in pulmonary embolism Year: 2017 Warfarin-associated intracranial hemorrhage during anticoagulation therapy Source: International Congress 2014 – Acute pulmonary embolism Year: 2014 Prognosis factors of recurrent pulmonary thromboembolism Source: International Congress 2014 – Acute pulmonary embolism Year: 2014 Pulmonary Hypertension in Childhood Source: Virtual Congress 2020 – From the bronchoscope to the clinic: paediatric bronchology at a glance Year: 2020